Did some DD and this is on their home page, they see revenues for 2015 to come in around 5 and a half million.You'll find it at 2013 results.As a result of reading that I bailed just now and made a little.ISR is not gonna make any money near term.Long term at the rate their going who knows.Bottom linen in my opinion get out if you've made some bucks cause this could very well go the way of CYTR and MNGA,I'm sure the well informed know where I'm comeing from.GLTA
I thought this was a spec play? They ramp it up on good news. It fell back to consolidate below $2 even after offering 4-5 million shares at $2.60. Now it climbs above offering and nears 52 week high set last week. They are presenting data and findings of FDA approved treatment for 3 days. I don't know? For me it looks and has been a winner, I'm well in the money here. I am holding a nice position from here out. The one thing that caught my eye during big run up was trading 200,000,000 shares! Float says 35-40 million. I've been in some trade hurricanes but this traded 7 times TOS 2 days. That I've never seen but very impressed. GLTA
I see, now it's very clear - you're going to base your investment here solely on an analyst's projection. So let us all understand what you're saying: you bought ISR on a whim, and then decided to check their website where you found this analyst report, and based on that you bailed - hmmm...that all makes perfect sense to me. BTW, good luck with that investment strategy of yours.
Sentiment: Strong Buy
First off, what exact filing (page no.?) are your referring to with a 2015 projection? Have you gone through their latest 10-Q...I think not. IsoRay's fundamentals are like none-other for a micro-cap Bio Science company trading in this range. It appears that you're new to trading Bio's, as typically the market gives them a valuation based on forward-looking projections - have you ever checked to see how may Bio's are trading above $5 with NO REVENUE, with a market cap 5 times higher than IsoRay's? Go ahead and name all the Bio's trading @ $3 with an FDA approved anti-cancer delivery system, with a market-cap of only $162 million. I don't know what kind of DD you think you've done here, but, in my estimation it wasn't very thorough! GLTY
Sentiment: Strong Buy
So based on this run rate.. they are already at 20 million plus this year.. plus all the new hype they are getting this puts them well over 30 million for the hear.. and no debt.. I wouldnt go far folks.. this may dip.. but she's going to run big time next week.